-
Je něco špatně v tomto záznamu ?
p38 MAPK Is Activated but Does Not Play a Key Role during Apoptosis Induction by Saturated Fatty Acid in Human Pancreatic β-Cells
J. Šrámek, V. Němcová-Fürstová, K. Balušíková, P. Daniel, M. Jelínek, RF. James, J. Kovář,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2000
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
26861294
DOI
10.3390/ijms17020159
Knihovny.cz E-zdroje
- MeSH
- aktivace enzymů MeSH
- apoptóza * účinky léků MeSH
- beta-buňky účinky léků metabolismus MeSH
- buněčné linie MeSH
- exprese genu MeSH
- inhibitory proteinkinas farmakologie MeSH
- kyseliny stearové farmakologie MeSH
- lidé MeSH
- MAP kinasový signální systém účinky léků MeSH
- mastné kyseliny metabolismus farmakologie MeSH
- mitogenem aktivované proteinkinasy p38 antagonisté a inhibitory metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Saturated stearic acid (SA) induces apoptosis in the human pancreatic β-cells NES2Y. However, the molecular mechanisms involved are unclear. We showed that apoptosis-inducing concentrations of SA activate the p38 MAPK signaling pathway in these cells. Therefore, we tested the role of p38 MAPK signaling pathway activation in apoptosis induction by SA in NES2Y cells. Crosstalk between p38 MAPK pathway activation and accompanying ERK pathway inhibition after SA application was also tested. The inhibition of p38 MAPK expression by siRNA silencing resulted in a decrease in MAPKAPK-2 activation after SA application, but it had no significant effect on cell viability or the level of phosphorylated ERK pathway members. The inhibition of p38 MAPK activity by the specific inhibitor SB202190 resulted in inhibition of MAPKAPK-2 activation and noticeable activation of ERK pathway members after SA treatment but in no significant effect on cell viability. p38 MAPK overexpression by plasmid transfection produced an increase in MAPKAPK-2 activation after SA exposure but no significant influence on cell viability or ERK pathway activation. The activation of p38 MAPK by the specific activator anisomycin resulted in significant activation of MAPKAPK-2. Concerning the effect on cell viability, application of the activator led to apoptosis induction similar to application of SA (PARP cleavage and caspase-7, -8, and -9 activation) and in inhibition of ERK pathway members. We demonstrated that apoptosis-inducing concentrations of SA activate the p38 MAPK signaling pathway and that this activation could be involved in apoptosis induction by SA in the human pancreatic β-cells NES2Y. However, this involvement does not seem to play a key role. Crosstalk between p38 MAPK pathway activation and ERK pathway inhibition in NES2Y cells seems likely. Thus, the ERK pathway inhibition by p38 MAPK activation does not also seem to be essential for SA-induced apoptosis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000500
- 003
- CZ-PrNML
- 005
- 20170118112702.0
- 007
- ta
- 008
- 170103s2016 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms17020159 $2 doi
- 024 7_
- $a 10.3390/ijms17020159 $2 doi
- 035 __
- $a (PubMed)26861294
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Šrámek, Jan $u Division of Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Ruská 87, Prague 110 00, Czech Republic. jan.sramek@seznam.cz.
- 245 10
- $a p38 MAPK Is Activated but Does Not Play a Key Role during Apoptosis Induction by Saturated Fatty Acid in Human Pancreatic β-Cells / $c J. Šrámek, V. Němcová-Fürstová, K. Balušíková, P. Daniel, M. Jelínek, RF. James, J. Kovář,
- 520 9_
- $a Saturated stearic acid (SA) induces apoptosis in the human pancreatic β-cells NES2Y. However, the molecular mechanisms involved are unclear. We showed that apoptosis-inducing concentrations of SA activate the p38 MAPK signaling pathway in these cells. Therefore, we tested the role of p38 MAPK signaling pathway activation in apoptosis induction by SA in NES2Y cells. Crosstalk between p38 MAPK pathway activation and accompanying ERK pathway inhibition after SA application was also tested. The inhibition of p38 MAPK expression by siRNA silencing resulted in a decrease in MAPKAPK-2 activation after SA application, but it had no significant effect on cell viability or the level of phosphorylated ERK pathway members. The inhibition of p38 MAPK activity by the specific inhibitor SB202190 resulted in inhibition of MAPKAPK-2 activation and noticeable activation of ERK pathway members after SA treatment but in no significant effect on cell viability. p38 MAPK overexpression by plasmid transfection produced an increase in MAPKAPK-2 activation after SA exposure but no significant influence on cell viability or ERK pathway activation. The activation of p38 MAPK by the specific activator anisomycin resulted in significant activation of MAPKAPK-2. Concerning the effect on cell viability, application of the activator led to apoptosis induction similar to application of SA (PARP cleavage and caspase-7, -8, and -9 activation) and in inhibition of ERK pathway members. We demonstrated that apoptosis-inducing concentrations of SA activate the p38 MAPK signaling pathway and that this activation could be involved in apoptosis induction by SA in the human pancreatic β-cells NES2Y. However, this involvement does not seem to play a key role. Crosstalk between p38 MAPK pathway activation and ERK pathway inhibition in NES2Y cells seems likely. Thus, the ERK pathway inhibition by p38 MAPK activation does not also seem to be essential for SA-induced apoptosis.
- 650 12
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a mastné kyseliny $x metabolismus $x farmakologie $7 D005227
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a beta-buňky $x účinky léků $x metabolismus $7 D050417
- 650 _2
- $a MAP kinasový signální systém $x účinky léků $7 D020935
- 650 _2
- $a inhibitory proteinkinas $x farmakologie $7 D047428
- 650 _2
- $a kyseliny stearové $x farmakologie $7 D013229
- 650 _2
- $a mitogenem aktivované proteinkinasy p38 $x antagonisté a inhibitory $x metabolismus $7 D048051
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Němcová-Fürstová, Vlasta $u Division of Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Ruská 87, Prague 110 00, Czech Republic. vlasta.furstova@tiscali.cz.
- 700 1_
- $a Balušíková, Kamila $u Division of Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Ruská 87, Prague 110 00, Czech Republic. kamila.balusikova@lf3.cuni.cz.
- 700 1_
- $a Daniel, Petr $u Division of Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Ruská 87, Prague 110 00, Czech Republic. petr85daniel@gmail.com.
- 700 1_
- $a Jelínek, Michael $u Division of Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Ruská 87, Prague 110 00, Czech Republic. michael.j@email.cz.
- 700 1_
- $a James, Roger F $u Department of Infection, Immunity and Inflammation, Maurice Shock Medical Sciences Building, University of Leicester, University Road, Leicester LE1 9HN, UK. rj1@leicester.ac.uk.
- 700 1_
- $a Kovář, Jan $u Division of Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Ruská 87, Prague 110 00, Czech Republic. jan.kovar@lf3.cuni.cz.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 17, č. 2 (2016), s. 159
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26861294 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170118112809 $b ABA008
- 999 __
- $a ok $b bmc $g 1179640 $s 961067
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 17 $c 2 $d 159 $e 20160205 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- LZP __
- $a Pubmed-20170103